Receptor tyrosine kinase activation: From the ligand perspective

R Trenker, N Jura - Current opinion in cell biology, 2020 - Elsevier
… conserved intracellular kinase domains are coupled to divergent extracellular modules. The
extracellular domains initiate receptor signaling upon binding to either soluble or membrane-…

T cell receptor (TCR) signaling in health and disease

K Shah, A Al-Haidari, J Sun, JU Kazi - Signal transduction and targeted …, 2021 - nature.com
membrane, cytoplasm, and nucleus. T cell signaling is thus important for efficient T cell
conserved regulatory domains (SH3 and SH2), a protein tyrosine kinase domain (SH1), a C-…

Akt-ing up just about everywhere: compartment-specific Akt activation and function in receptor tyrosine kinase signaling

MG Sugiyama, GD Fairn, CN Antonescu - Frontiers in Cell and …, 2019 - frontiersin.org
signaling underlies the pathology of many diseasesmembrane traffic and sorting. CME
has been described in the context of cell signaling as an essential regulator of EGFR signaling

Receptor tyrosine kinases and cancer: oncogenic mechanisms and therapeutic approaches

P Saraon, S Pathmanathan, J Snider, A Lyakisheva… - Oncogene, 2021 - nature.com
Receptor tyrosine kinases (RTKs) are transmembrane receptors of great clinical interest due
to their role in disease… , with numerous small molecule-based tyrosine kinase inhibitor (TKI) …

Exploring receptor tyrosine kinases-inhibitors in Cancer treatments

DS Metibemu, OA Akinloye, AJ Akamo, DA Ojo… - … of Medical Human …, 2019 - Springer
domain, a single transmembrane helix, and an intracellular region that contains a juxtamembrane
regulatory region, a tyrosine kinase domain (… the incidence of many diseases in which …

AXL receptor tyrosine kinase as a promising anti-cancer approach: functions, molecular mechanisms and clinical applications

C Zhu, Y Wei, X Wei - Molecular cancer, 2019 - Springer
… Cancer is not a single-cell disease but rather the result of complex … of receptor tyrosine
kinases (RTKs). AXL is composed of an extracellular, transmembrane and intracellular domain [8]. …

Protein tyrosine phosphatase receptor type C (PTPRC or CD45)

MA Al Barashdi, A Ali, MF McMullin… - … of clinical pathology, 2021 - jcp.bmj.com
… except for mature erythrocytes, and is an essential regulator of T and B cell antigen
receptor-mediated activation. Disruption of the equilibrium between protein tyrosine kinase and …

Protein kinase CK2: a potential therapeutic target for diverse human diseases

C Borgo, C D'Amore, S Sarno, M Salvi… - Signal transduction and …, 2021 - nature.com
… Depiction of the most relevant CK2 interventions on cellular signaling pathways. Double
arrows indicate a dynamic equilibrium that moves toward the longest arrow direction; inhibitions …

Conceptual evolution of cell signaling

A Nair, P Chauhan, B Saha, KF Kubatzky - International journal of …, 2019 - mdpi.com
… -specific protein tyrosine kinase (Lck) and inhibits TCR signaling at the … signaling components,
and its role in a particular disease. In the case of diseases like cancer, multiple signaling

Beyond TCR signaling: emerging functions of Lck in cancer and immunotherapy

U Bommhardt, B Schraven, L Simeoni - International journal of molecular …, 2019 - mdpi.com
… (Lck) is a member of the Src family of protein tyrosine kinaseshuman diseases in which
Lck plays a pathological role. Since Lck plays a role in cancer cell signaling as well as in T-cell